Common cancer risk and statins: a population-based case–control study in a Chinese population

Bibliography

• Sewester CS, Dombek CE, Olin BR, Drug facts and comparisons. 65th edition. Lippincott Williams & Wilkins; New York, NY: 2010
   Google Scholar
• Chen BK. Three essays on physician prescribing behavior. Available from: http://www.slidefinder.net/t/three_essays_physician_prescribing_behavior/1984349 [Accessed 21 June 2011]
   Google Scholar
• Pharmaceutical Industry. Available from: http://www.itis.org.tw/itisdata/English/itispo-0453s702(97)_02-13_22.pdf [Accessed 21 June 2011]
   Google Scholar
• Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer's disease. Neuroepidemiology 2004;23:94-8
   PubMed Web of Science ®Google Scholar
• Chan KA, Andrade SE, Boles M, Inhibitors of hy- droxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-8
   PubMed Web of Science ®Google Scholar
• Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-16
   PubMed Web of Science ®Google Scholar
• Meier CR, Schlienger RG, Kraenzlin ME, HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283:3205-10
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Olsen ML, Johnsen SP, Hip fracture risk in statin users—a population-based Danish case-control study. Osteoporos Int 2004;15:452-8
   PubMed Web of Science ®Google Scholar
• Jakobisiak M, Golab J. Potential antitumor effects of statins. Int J Oncol 2003;23:1055-69
   PubMed Web of Science ®Google Scholar
• Wong WW, Dimitroulakos J, Minden MD, HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19
   PubMed Web of Science ®Google Scholar
• Dimitroulakos J, Marhin WH, Tokunaga J, Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinoma. Neoplasia 2002;4:337-46
   PubMed Web of Science ®Google Scholar
• Park HJ, Hong D, Iruela-Arispe L, 3-hydroxy-3-methylglutarylcoenzyme a reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 2002;91:143-50
   PubMed Web of Science ®Google Scholar
• Weis M, Heeschen C, Glassford AJ, Statins have biphasic effects on angiogenesis. Circulation 2002;105:739-45
   PubMed Web of Science ®Google Scholar
• Alonso DF, Farina HG, Skilton G, Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Breast Cancer Res Treat 1998;50:83-93
   PubMed Web of Science ®Google Scholar
• Kusama T, Mukai M, Iwasaki T, 3-hydroxy-3-methylglutarylcoenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 2002;122:308-17
   PubMed Web of Science ®Google Scholar
• John S, Schneider MP, Delles C, Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 2005;149:473; e471-473.e410
   PubMedGoogle Scholar
• Endres M. Statins: Potential new indications in inflammatory conditions. Atheroscler Suppl 2006;7:31-5
   PubMed Web of Science ®Google Scholar
• Setoguchi S, Glynn RJ, Avorn J, Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 2007;115(1):27-33
   PubMed Web of Science ®Google Scholar
• Boudreau DM, Yu O, Johnson J. Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 2010;9(4):603-21
   PubMed Web of Science ®Google Scholar
• Boudreau DM, Yu O, Miglioretti DL, Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev 2007;16(3):416-21
   PubMed Web of Science ®Google Scholar
• Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology 2007;18(2):213-19
   PubMed Web of Science ®Google Scholar
• Friedman GD, Flick ED, Udaltsova N, Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf 2008;17(1):27-36
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Rodriguez C, Brady KA, Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst 2006;98(1):69-72
   PubMed Web of Science ®Google Scholar
• Yang YX, Hennessy S, Propert K, Chronic statin therapy and the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2008;17(9):869-76
   PubMed Web of Science ®Google Scholar
• Boudreau D, Yu O, Buist D, Miglioretti D. Statin use and prostate cancer risk in a large population based setting. Cancer Causes Control 2008;19(17):767-74
   PubMedGoogle Scholar
• Agalliu I, Salinas CA, Hansten PD, Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 2008;168(3):250-60
   PubMed Web of Science ®Google Scholar
• Boudreau DM, Gardner JS, Malone KE, The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer 2004;100(11):2308-16
   PubMed Web of Science ®Google Scholar
• Coogan PF, Smith J, Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst 2007;99(1):32-40
   PubMed Web of Science ®Google Scholar
• Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer 2007;121(6):1325-30
   PubMed Web of Science ®Google Scholar
• Flick ED, Habel LA, Chan KA, Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs 2009;69(11):1445-57
   PubMed Web of Science ®Google Scholar
• Friis S, Poulsen AH, Johnsen SP, Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114(4):643-7
   PubMed Web of Science ®Google Scholar
• Haukka J, Sankila R, Klaukka T, Incidence of cancer and statin usage–record linkage study. Int J Cancer 2010;126(1):279-84
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Taiwan Cancer Registry. Available from: http://www.mc.ntu.edu.tw/CRS/main.php?Page=N2
   Google Scholar
• Application of ATC code. Available from: http://www.whocc.no/atc/application_for_atc_codes/ [Accessed: 2011-3-628]
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
   PubMedGoogle Scholar
• Chiu HF, Ho SC, Chang CC, Statins are associated with a reduced risk of gastric cancer: a population-based case-control study. Am J Gastroenterol 2011;106(12):2098-103
   PubMed Web of Science ®Google Scholar
• Heiss G, Wallace R, Anderson GL, Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. JAMA 2008;299:1036-45
   PubMed Web of Science ®Google Scholar
• Kuoppala J, Lamminpää A, Pukkala E. Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 2008;44(15):2122-32
   PubMed Web of Science ®Google Scholar
• Chiu HF, Ho SC, Chen CC, Yang CY. Statin use and the risk of liver cancer: a population-based case–control study. Am J Gastroenterol 2011;106(5):894-8
   PubMed Web of Science ®Google Scholar
• Kuo CC, Chiu HF, Lee IM, Statin use and the risk of bladder cancer: a population-based case-control study. Expert Opin Drug Saf 2012;11(5):733-8
   PubMed Web of Science ®Google Scholar
• Chiu HF, Kuo CC, Kuo HW, Statin use and the risk of kidney cancer: a population-based case-control study. Expert Opin Drug Saf 2012;11(4):543-9
   PubMed Web of Science ®Google Scholar
• Cheng MH, Chiu HF, Ho SC, Statin use and the risk of colorectal cancer: a population-based case-control study. World J Gastroenterol 2011;17(47):5197-202
   PubMed Web of Science ®Google Scholar
• Cheng MH, Chiu HF, Ho SC, Yang CY. Statin use and the risk of female lung cancer: a population-based case-control study. Lung Cancer 2012;75(3):275-9
   PubMed Web of Science ®Google Scholar
• Chiu HF, Chang CC, Ho SC, Statin use and the risk of pancreatic cancer: a population-based case-control study. Pancreas 2011;40(5):669-72
   PubMed Web of Science ®Google Scholar
• Chang CC, Ho SC, Chiu HF, Yang CY. Statins increase the risk of prostate cancer: a population-based case-control study. Prostate 2011;71(16):1818-24
   PubMed Web of Science ®Google Scholar
• Gauthaman K, Fong CY, Bongso A. Statins, stem cells, and cancer. J Cell Biochem 2009;106:975e83
   Google Scholar
• Baigent C, Keech A, Kearney PM, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78
   PubMed Web of Science ®Google Scholar
• Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer insights from large randomized statin trials. J Am Coll Cardiol 2007;50:409-18
   PubMed Web of Science ®Google Scholar
• Marelli C, Gunnarsson C, Ross S, Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol 2011;58(5):530-7
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Price JF, Fowkes FG, Short term effects of daily aspirin on cancer incidence mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012;379:1602-12
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Wilson M, Price JF, Effect of daily aspirin on risk of cancer metastasis. A study of incident cancers during randomized controlled trials. Lancet 2012;379:1591-601
   PubMed Web of Science ®Google Scholar
• Chan AT, Cook NR. Are you ready to recommend aspirin for cancer prevention? Lancet 2012;379:1569-71
   PubMed Web of Science ®Google Scholar
• Sahra IB, Marchand-Brustel YL, Tanti JF, Bost F. Metformin in cancer therapy : a new perspective for an old diabetic drug? Mol Cancer Ther 2010;9(5):1092-9
   PubMed Web of Science ®Google Scholar
• Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: a meta-analysis of 6 randomized clinical trials and 13 observational studies. Int J Can 2008;123:899-904
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002;360(9326):7-22
   PubMed Web of Science ®Google Scholar
• Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Gastroenterology 2007;133(2):393-402
   PubMed Web of Science ®Google Scholar